Y-Intercept (Hong Kong) Ltd - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.

Quarter-by-quarter ownership
Y-Intercept (Hong Kong) Ltd ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$114,064
-65.2%
13,644
+3.4%
0.01%
-68.6%
Q2 2023$327,863
+66.6%
13,199
-60.3%
0.04%
+75.0%
Q3 2022$196,745
-79.2%
33,234
+85.6%
0.02%
-95.0%
Q4 2020$947,00017,9080.40%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 5,434,783$60,326,0005.25%
RA Capital Management 9,880,323$109,672,0003.33%
BRIDGER MANAGEMENT, LLC 1,907,492$21,173,0001.53%
Eversept Partners, LP 776,323$8,617,1851.52%
Opaleye Management Inc. 579,651$6,434,0001.26%
Sofinnova Investments, Inc. 811,292$9,006,0000.65%
Ikarian Capital, LLC 316,200$3,510,0000.57%
ARMISTICE CAPITAL, LLC 800,000$8,880,0000.51%
683 Capital Management, LLC 398,271$4,421,0000.51%
Frontier Wealth Management LLC 196,750$2,184,0000.35%
View complete list of TG THERAPEUTICS INC shareholders